Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan 30 mg Efficacy in Essential Hypertension
NCT01878201Phase 2Completed
- Sponsor
- Boryung
- Start
- May 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fimasartan in essential hypertension, sponsored by Boryung. Started May 2013; status: completed.
02
Drugs
fimasartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01878201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878201.